are glp-1 receptor agonists banned by wada 2025 The World Anti-Doping Agency Is 'Monitoring' Use at the 2026 Milan Winter Olympics GLP-1 weight-loss drugs are a

By interacting with GLP-1 receptors in the brain, semaglutide GLP-1 helps to curb appetite and promote a sense of fullness, making it easier for individuals to adhere to a reduced-calorie diet

These drugs are currently approved in India only under strict medical conditions and are designated as prescription-only medications

44 , D733D745 (2016)

Tsukiyama K, Yamada Y, Yamada C, et al

While semaglutide GLP-1 is highly effective, it is important to address potential gastrointestinal side effects, such as nausea and diarrhea, which are generally transient and manageable

About 7% of participants taking Wegovy dropped out due to adverse events (versus 3% with placebo)